A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
Clinical trial NCT06650852 · RECRUITING
Trial details
- NCT number
- NCT06650852
- Sponsor
- Brii Biosciences Limited
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-31
- Primary completion
- 2026-07-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.